HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.16

EPS Forecast

$294.4

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
CRBUCaribou Biosciences IncIOVAIovance Biotherapeutics IncDNLIDenali Therapeutics Inc